ALBANY, New York, August 7, 2017 /PRNewswire/ --
A recent intelligence study by Transparency Market Research (TMR)has detected that the global allergy treatment market is dominated by ALK-Abelló A/S when it comes to immunotherapy, whereas GlaxoSmithKline plc. Holds the pole position in the market in terms of anti-allergic drugs. The positions hold true for the base
As per the projections of the TMR report, the global allergy treatment market will be worth US$41.17 bn by the end of 2025, incrementing the demand at a healthy CAGR of 5.5% during the forecast period of 2017 to 2025, adding significantly to its evaluated valuation of US$25.50 bn in 2016. The report notes the presence of quite a few local and regional players, while naming some of other prominent players such as Allergan, HAL Allergy Group, Meda Pharmaceuticals Inc., Allergy Therapeutics, Sunovion Pharmaceuticals Inc., Allergon AB, and Teva Pharmaceutical. In the near future, the report expects increased focus on high safety and efficacy drugs for the treatment of asthma and allergic rhinitis by these leading companies in order to gain advantage over their competitors.
Inhaled Allergy Segment Serves Maximum Demand
Based on allergy type, this TMR report observes significantly stronger prevalence and consequent demand for inhaled allergy segment than food allergy and drug allergy. Allergic asthma and allergic rhinitis are two of the most common type of inhaled allergy. Treatment-wise, antihistamines accounted for the maximum demand in 2016, flourishing as a highly profitable sub-category of anti-allergy treatment. That being said, relentless research and development in the treatment category of immunotherapy is anticipated to turn lucrative through the course of the forecast period. Geographically, the report rates North America as most profitable region, serving high volume of demand as a result of growing life science industry and rising focus on research and new drug development in the developed country of the U.S.
Get Sample PDF Report Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11357
Prevalence of Asthma Sustaining Solid Demand
Presence of high unmet medical needs in various emerging economies, existence of novel molecules in pipeline, increasing prevalence of allergic rhinitis and asthma, growing consumption of tobacco, which is the primary cause of lung cancer, and upsurge of allergies as a result of environmental pollution are some of the key factors driving the demand in the global allergy treatment market. Owing to the prevalence of tobacco-caused allergic diseases, various governments across the globe have incremented their efforts to impart awareness and are offering opportunities for the vendors of this market to serve to the masses.
On the other hand, increased preference of complementary and alternative medicines (CAM), poor patient adherence and high dropout rates, lack of healthcare infrastructure in various potential countries, and high cost of allergic immunotherapy are some of the factors hindering the allergy treatment market from attaining its true potential. Nevertheless, the companies operating in the global allergy treatment market are expected to gain from a few emerging trends such as sublingual immunotherapy (SLIT), advent of SPIRE, identification of new allergen targets, and strategic alliances between prominent and promising players for novel drug development.
The information presented in this review is based on a Transparency Market Research report, titled, "Allergy Treatment Market - (Allergy type: Food Allergy, Inhaled Allergy, and Drug Allergy; Treatment - Anti-allergy Drugs (Antihistamines, Corticosteroids, and Leukotriene Inhibitors) and Immunotherapy (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT)); Distribution Channel - Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025."
Key Segments of the Global Allergy Treatment Market
Allergy treatment Market, by Allergy Type
Allergy treatment Market, by Treatment
- Anti-allergy Drugs
Allergy treatment Market, by Distribution Channel
Global Allergy treatment Market, by Major Region
- North America
- Latin America
- Middle East & Africa
Browse Research Press Release: http://www.transparencymarketresearch.com/pressrelease/allergy-treatment-market.htm
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Transparency Market Research State Tower 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: firstname.lastname@example.org
Website: http://www.transparencymarketresearch.com Blog: http://www.editiontruth.com/
SOURCE Transparency Market Research
Subscribe to our Free Newsletters!
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...